Generous Pledge Creates the Omar Boraie Chair at Rutgers Cancer Institute

Posted on March 19, 2017 By

Rutgers University has established a new Chair in Genomic Science from a generous donation from Omar Boraie. The creation of this new endowed chair is to foster oncology research and precision medicine to better treat patients. This story was reported by Newswise in 2015, found here.


The scientific advancement began when an anonymous donor gave a $1.5 million match for each of the establishment of 18 new chairs. This began the ’18 Chair Challenge’ campaign at Rutgers. Then Boraie kindly supported the donation with a $1.5 million match, resulting in the $3 million endowed Omar Boraie Chair in Genomic Science at the Rutgers Cancer Institute of New Jersey.


Omar Boraie is a New Brunswick developer with a background in chemistry and an interest in cancer research. Boraie is hopeful that his donation will yield significant advances in the field of precision medicine to help treat patients with unresponsive cancers. The creation of an endowed chair will place an established physician scientist in a renowned position with the commitment to further scientific research for translation to clinic.


The honor of the Omar Boraie Chair was given to Shridar Ganesa, MD, PhD. Dr. Ganesan is an associate director for translational research at Rutgers Cancer Institute and an associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School. His dedication to translational research is apparent, as he is also head of a precision medicine clinical trial at Rutgers Cancer Institute. Dr. Ganesan is well known as both a scientific researcher and a clinician. Before coming to Rutgers in 2005, he was as the Dana-Farber Cancer Institute at Harvard Medical School.


Precision medicine in oncology research is a valuable tool for finding the most effective treatment for the cancer of individuals. Initially, cancer treatments were broadly used to fight all kinds of tumors in many patients. With scientific advancements in the fields of oncology and genomics, clinicians are starting to understand why some patients have better outcomes than others. Precision medicine will allow clinicians to determine exactly which type of tumor they are finding, which will them allow them to customize an optimal treatment plan for that individual patient’s cancer.


By naming Dr. Shridar Ganesa to the Omar Boraie Chair in Genomic Science, Rutgers Cancer Institute in New Jersey is committed to developing precision medicine to help fight cancer in every individual patient.


Business LeadersBusiness World